4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-25-021177
CHIEF ACCOUNTING OFFICER sold 17,000 shares at $32.35 ($549,950)
- CHIEF ACCOUNTING OFFICER acquired 17,000 shares (option exercise)
- CHIEF ACCOUNTING OFFICER acquired 495 shares (grant or award)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2025-07-15 | Grant or award 10b5-1 | +495 | $15.63 | $7,737 | 33,041 | D |
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2025-08-04 | Option exercise 10b5-1 | +17,000 | $15.52 | $263,840 | 50,041 | D |
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2025-08-04 | Sale 10b5-1 | −17,000 | $32.35 | $549,950 | 33,041 | D |
| Derivatives | |||||||
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2025-08-04 | Option exercise · Share Option 10b5-1 | −17,000 | 0 | D | ||
| Open-market sales · 17,000 sh · avg $32.35 · $549,950 | |||||||
Loading xslF345X05/form4-08062025_040801.xml…